Researchers testing the role of a mysterious gene have identified a new target for drugs designed to treat anxiety.
“It’s the first study to show that it’s the copy number variant that has the potential to change Glo1 expression and behavior,” says Margaret Distler, an MD/PhD student in the Pritzker School of Medicine’s Medical Scientist Training Program at the University of Chicago.
“Our study was a physiological representation of what it means to increase Glo1 expression for anxiety.”
Full story at Futurity.
More research news from top universities.
Photo credit: Fotolia